Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehta, S.
Right arrow Articles by Stewart, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehta, S.
Right arrow Articles by Stewart, T. E.
(Chest. 2004;126:518-527.)
© 2004 American College of Chest Physicians

High-Frequency Oscillatory Ventilation in Adults*

The Toronto Experience

Sangeeta Mehta, MD; John Granton, MD, FCCP; Rod J. MacDonald, RRCP; Dennis Bowman, BSc; Andrea Matte-Martyn, RRT; Thomas Bachman, MSHA; Terry Smith, MD and Thomas E. Stewart, MD, FCCP

* From the Mount Sinai Hospital (Drs. Mehta and Stewart, and Mssrs. MacDonald and Bowman), Toronto; the University Health Network (Dr. Granton and Ms. Matte-Martyn), Toronto; Sunnybrook and Womens’ College Health Sciences Center (Dr. Smith), University of Toronto, Toronto, ON, Canada; and California State University (Mr. Bachman), San Bernardino, CA.

Correspondence to: Sangeeta Mehta, MD, Mount Sinai Hospital, 600 University Ave, No. 1818, Toronto, ON, Canada, M5G 1X5; e-mail: geeta.mehta{at}utoronto.ca

Study objectives: To review the clinical experience with high-frequency oscillatory ventilation (HFOV) in three medical-surgical ICUs in Toronto, ON, Canada, and to describe patient characteristics, HFOV strategies, and outcomes.

Design and patients: Retrospective chart review of all patients treated with HFOV at three academic university-affiliated ICUs since 1998. The data extracted included patient demographics, etiology of respiratory failure, ventilator settings, and gas exchange and cardiovascular data from baseline to 72 h of treatment, as well as at the transition from HFOV to conventional ventilation (CV). Heart rate and BP were recorded at regular intervals in all patients, and hemodynamic data were recorded in 32 patients who had pulmonary artery catheters in place. Cointerventions and ICU mortality were also recorded.

Measurements and results: A total of 156 adults (67 women and 89 men; mean [± SD] age, 48 ± 18 years; mean acute physiology and chronic health evaluation [APACHE] II score, 23.8 ± 7.5) with severe ARDS (ie, mean PaO2/fraction of inspired oxygen [FIO2] ratio, 91 ± 48 mm Hg; mean oxygenation index [OI], 31 ± 14) who had received CV for a duration of 5.6 ± 7.6 days underwent 171 trials of HFOV. HFOV was discontinued within 4 h in 19 patients (12%) because of difficulties with oxygenation, ventilation, or hemodynamics. PaO2/FIO2 ratios and OI ([FIO2 x mean airway pressure x 100]/PaO2) improved significantly with the application of HFOV, and this benefit persisted for the 72-h study duration. Significant changes in hemodynamics following HFOV initiation included an increase in central venous pressure and a reduction in cardiac output (throughout the 72 h), and an increase in pulmonary artery occlusion pressure (at 3 and 6 h). Patients were treated with HFOV for 5.1 ± 6.3 days. The 30-day mortality rate was 61.7%. Pneumothorax occurred in 21.8% of patients, 43.6% of patients were treated with inhaled nitric oxide, and 37.2% of patients were treated with steroids. Independent predictors of mortality on multivariate analysis were older age, higher APACHE II score, lower pH at the initiation of HFOV, and a greater number of days receiving CV prior to HFOV.

Conclusions: HFOV has beneficial effects on PaO2/FIO2 ratios and OI, and may be an effective rescue therapy for adults with severe oxygenation failure. The early institution of HFOV may be advantageous.

Key Words: ARDS • high-frequency oscillation • high-frequency ventilation • mechanical ventilation • respiratory failure




This article has been cited by other articles:


Home page
ChestHome page
C. N. Sessler and K. Varney
Patient-Focused Sedation and Analgesia in the ICU
Chest, February 1, 2008; 133(2): 552 - 565.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. Fan, D. M. Needham, and T. E. Stewart
Ventilatory Management of Acute Lung Injury and Acute Respiratory Distress Syndrome
JAMA, December 14, 2005; 294(22): 2889 - 2896.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.